“…The effect sizes for individual NP tests and domain T-scores in our studies are in the same ranges as effect sizes observed in some large US cohort studies (Maki et al, 2015;Rubin et al, 2015). The proportion of cases in this study with impairment based on individual tests or domain T-scores (17-23%) is in line with our previous findings (Kanmogne et al, 2018;Kanmogne et al, 2010;Njamnshi et al, 2009;Njamnshi et al, 2008) and some previously reported prevalence of HAND in Nigeria (21.5%) (Yusuf et al, 2017) and South Africa (23%) (Joska, Fincham, Stein, Paul, & Seedat, 2010). However, these are much lower than HAND prevalence reported among HIV-infected adults in other studies in Nigeria, China, and India (26-28%) (Jumare et al, 2019;Royal et al, 2012); South Africa (36-53%) (Joska et al, 2011;Mogambery, Dawood, Wilson, & Moodley, 2017), Botswana (37-38%) (Lawler et al, 2011), Zambia (34-35%) (Kabuba et al, 2017), Uganda (38-64%) (Nakku, Kinyanda, & Hoskins, 2013;Sacktor et al, 2019;Yechoor et al, 2016), and the United States (36-45%) (Heaton et al, 2015).…”